Merck & Co Inc (MRK)
82.46
-0.73 -0.88%
NYSE
Jan 20, 20:00
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 47.35B |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | 4.52 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | 11.52B |
Profitability | |
Gross Profit Margin (Quarterly) | 72.27% |
Profit Margin (Quarterly) | 23.43% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 3.01% |
Price and Valuation | |
Market Cap | 208.63B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 4.432 |
PE Ratio | 18.24 |
Price to Book Value | 7.148 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 0.9848 |
Free Cash Flow (Quarterly) | 657.00M |
Return on Equity | Upgrade |
View All MRK News
News
-
WireHeadlineTime (ET)
-
Yahoo01/20 15:40
-
Yahoo01/20 12:18
-
Yahoo01/20 12:10
-
SA Breaking News01/20 11:12
-
Yahoo01/20 09:00
-
PR Newswire01/20 09:00
-
SA Breaking News01/20 08:11
-
MT Newswires01/20 07:16
-
SA Breaking News01/20 07:14
-
Yahoo01/20 06:45
-
SA Breaking News01/19 16:47
-
Yahoo01/19 16:11
-
Yahoo01/19 13:50
-
Yahoo01/19 09:31
-
SA Breaking News01/19 09:05
-
Yahoo01/19 08:05
-
SA Breaking News01/15 15:00
-
SA Breaking News01/15 13:40
-
Yahoo01/15 08:14
-
Yahoo01/14 17:45
View All Events
Events
Date | Type | Description |
---|---|---|
02/04/2021 | Earnings | Merck & Co Inc Fourth Quarter Earnings Result for 2020 |
02/04/2021 08:00 EST | Misc | Merck & Co Inc Fourth Quarter Earnings Conference Call for 2020 |
12/14/2020 | Dividends | Amount: 0.65, Declared Date: Nov 11 2020, Pay Date: Jan 08 2021 |
10/27/2020 08:00 EDT | Misc | Merck & Co Inc Third Quarter Earnings Conference Call for 2020 |
10/27/2020 | Earnings | Merck & Co Inc Third Quarter Earnings in 2020 Release |
09/14/2020 | Dividends | Amount: 0.61, Declared Date: Jul 28 2020, Pay Date: Oct 07 2020 |
07/31/2020 08:00 EDT | Misc | Merck & Co Inc Second Quarter Earnings Conference Call for 2020 |
07/31/2020 | Earnings | Merck & Co Inc Second Quarter Earnings in 2020 Release |
06/12/2020 | Dividends | Amount: 0.61, Declared Date: May 26 2020, Pay Date: Jul 07 2020 |
05/26/2020 09:00 EDT | Misc | Merck & Co Inc Annual General Meeting for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.merck.com
- Investor Relations URL: http://investors.merck.com/investors/default.aspx
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Value
- Next Earnings Release: Feb. 04, 2021
- Last Earnings Release: Oct. 27, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Dec. 14, 2020
- Description: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 82.46 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
XLV | Health Care Select Sector SPDR® ETF | 4.80% |
VDIGX | Vanguard Dividend Growth Inv | 2.70% |
VIVAX | Vanguard Value Index Inv | 1.44% |
VTV | Vanguard Value ETF | 1.44% |
FWWMX | American Funds Washington Mutual 529-F-3 | 1.05% |
IVV | iShares Core S&P 500 ETF | 0.66% |
SPY | SPDR® S&P 500 ETF Trust | 0.65% |
VFINX | Vanguard 500 Index Investor | 0.65% |
VOO | Vanguard S&P 500 ETF | 0.65% |
VINIX | Vanguard Institutional Index I | 0.65% |
VSTSX | Vanguard Total Stock Mkt Idx Instl Sel | 0.54% |
VTI | Vanguard Total Stock Market ETF | 0.54% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MRK Tweets Stocktwits
Advertisement